Xortx Therapeutics Inc (XRTX) Stock Price, Quote & News

Company Profile

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, w...

Industry: Biotechnology

Sector: Healthcare

Phone: 403 455 7727

Website: www.xortx.com

Address:

3710 – 33rd Street NW, Calgary, Canada

TheFollower Oct. 23 at 9:14 PM

$XRTX $GPUS both brewing well tonight, tomorrow is Friday!

1 · Reply

Robcfg Oct. 23 at 7:13 PM

$XRTX looking good

0 · Reply

ProfitFireStorm Oct. 23 at 5:43 PM

$XRTX Big move coming!!! 🌋🌋🌋🌋🌋🌋🌋🌋

0 · Reply

riddle11 Oct. 23 at 3:36 PM

$XRTX just started a position

0 · Reply

Dickman777 Oct. 23 at 3:33 PM

$XRTX 🫠🤑

0 · Reply

TheFollower Oct. 23 at 3:27 PM

$XRTX started a position here 🍻🚀

0 · Reply

Moneymastermind99 Oct. 23 at 3:16 PM

$AIRE $SCNX $XRTX Peep TGL 😉🤫

0 · Reply

DaBullRunner Oct. 23 at 3:11 PM

$SCNX $AIRE read what I said below👇🏝️✅ $XRTX is our next one I tell you 🚨🚨🚨🚨

2 · Reply

DaBullRunner Oct. 23 at 3:06 PM

$SCNX said what I said and now I’m getting PAID👇 $AIRE remember what I said????🤑 $XRTX keep ignoring me 🚨🚨🚨 👈🚢📦📦📦📦 $DVLT told you in the .40’s ✅ $BYND told you in the .50’s ✅

0 · Reply

BTB1027 Oct. 23 at 3:06 PM

$XRTX I’m in

0 · Reply

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

Oct 20, 2025, 8:34 PM EDT - 4 days ago

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

Oct 20, 2025, 6:45 PM EDT - 4 days ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Oct 17, 2025, 7:00 AM EDT - 8 days ago

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Sep 3, 2025, 7:00 AM EDT - 7 weeks ago

XORTX Initiates IND Preparation for XORLO™ in Gout Program

Aug 8, 2025, 7:54 PM EDT - 2 months ago

XORTX Completes USD $114,500 Private Placement

Jul 22, 2025, 7:59 PM EDT - 3 months ago

XORTX Completes Non-Brokered Private Placement of Units

Jun 26, 2025, 7:00 AM EDT - 4 months ago

XORTX Announces USD $925,000 Private Placement

May 19, 2025, 7:00 AM EDT - 5 months ago

XORTX Announces USD $3 Million Offering

Apr 17, 2025, 7:45 PM EDT - 6 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Jan 17, 2025, 5:00 PM EST - 10 months ago

XORTX Announces Change of Auditor

Dec 12, 2024, 9:17 AM EST - 11 months ago

XORTX Announces Presentation at the Rare and Genetic Disease Summit

Oct 18, 2024, 4:00 PM EDT - 1 year ago

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 9, 2024, 5:00 AM EDT - 1 year ago

XORTX Initiates Precision Medicine Program

Sep 13, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

Sep 12, 2024, 5:30 PM EDT - 1 year ago

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

Sep 6, 2024, 5:30 PM EDT - 1 year ago

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Sep 3, 2024, 12:30 PM EDT - 1 year ago

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

Aug 23, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

Aug 20, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

May 17, 2024, 7:00 AM EDT - 1 year ago

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

Apr 30, 2024, 1:54 PM EDT - 1 year ago

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

Apr 22, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Publication of Key Research in ADPKD

Apr 8, 2024, 7:30 AM EDT - 1 year ago

XORTX Welcomes New Member to the Board of Directors

Mar 27, 2024, 5:00 AM EDT - 1 year ago

XORTX Announces New Clinical Advisory Board Member

Mar 19, 2024, 5:00 AM EDT - 1 year ago

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

Mar 4, 2024, 7:00 AM EST - 1 year ago

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

Feb 1, 2024, 8:46 PM EST - 1 year ago

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

Jan 15, 2024, 7:00 AM EST - 1 year ago

XORTX Announces $2 Million Public Offering

Jan 3, 2024, 7:00 AM EST - 1 year ago

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

Nov 30, 2023, 7:30 AM EST - 2 years ago

XORTX Announces US ATM Offering

Nov 29, 2023, 7:00 AM EST - 2 years ago

XORTX Meets Nasdaq Continued Listing Requirements

Nov 10, 2023, 7:00 AM EST - 2 years ago

XORTX Clarifies Timing for Share Consolidation

Nov 8, 2023, 5:00 PM EST - 2 years ago

XORTX Announces Share Consolidation

Oct 27, 2023, 5:30 PM EDT - 2 years ago

XORTX Announces Results of Special Meeting of Shareholders

Oct 25, 2023, 5:00 PM EDT - 2 years ago

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

Oct 25, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces Rescheduling of Special Meeting of Shareholders

Oct 12, 2023, 7:00 AM EDT - 2 years ago

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

Oct 4, 2023, 7:00 AM EDT - 2 years ago

XORTX Calls Special Meeting of Shareholders

Aug 29, 2023, 7:00 AM EDT - 2 years ago

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

Aug 4, 2023, 5:00 PM EDT - 2 years ago

XORTX Appoints Chief Financial Officer

Jun 23, 2023, 8:51 PM EDT - 2 years ago

XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company's Upcoming Annual and Special Meeting of Shareholders

May 24, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

Apr 21, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

Feb 1, 2023, 7:00 AM EST - 2 years ago

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

Jan 19, 2023, 7:00 AM EST - 3 years ago

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

Dec 8, 2022, 7:00 AM EST - 3 years ago

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Nov 28, 2022, 7:00 AM EST - 3 years ago

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study

Nov 16, 2022, 7:00 AM EST - 3 years ago

XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer

Nov 3, 2022, 5:00 PM EDT - 3 years ago

XORTX Presents New Proof of Concept Data at American Society of Nephrology

TheFollower Oct. 23 at 9:14 PM

$XRTX $GPUS both brewing well tonight, tomorrow is Friday!

1 · Reply

Robcfg Oct. 23 at 7:13 PM

$XRTX looking good

0 · Reply

ProfitFireStorm Oct. 23 at 5:43 PM

$XRTX Big move coming!!! 🌋🌋🌋🌋🌋🌋🌋🌋

0 · Reply

riddle11 Oct. 23 at 3:36 PM

$XRTX just started a position

0 · Reply

Dickman777 Oct. 23 at 3:33 PM

$XRTX 🫠🤑

0 · Reply

TheFollower Oct. 23 at 3:27 PM

$XRTX started a position here 🍻🚀

0 · Reply

Moneymastermind99 Oct. 23 at 3:16 PM

$AIRE $SCNX $XRTX Peep TGL 😉🤫

0 · Reply

DaBullRunner Oct. 23 at 3:11 PM

$SCNX $AIRE read what I said below👇🏝️✅ $XRTX is our next one I tell you 🚨🚨🚨🚨

2 · Reply

DaBullRunner Oct. 23 at 3:06 PM

0 · Reply

BTB1027 Oct. 23 at 3:06 PM

$XRTX I’m in

0 · Reply

DaBullRunner Oct. 23 at 3:03 PM

$SCNX told you $XRTX keep ignoring me here too You will soon be chasing like you are at SCNX👇 $AIRE $NMRA $MSAI let’s get it

1 · Reply

DaBullRunner Oct. 23 at 2:49 PM

$AIRE hate to say I told you so but….. $XRTX also loading this before the masses arrive like they did at $SCNX $BYND $HKPD 👇

1 · Reply

DaBullRunner Oct. 23 at 2:44 PM

$HKPD there it goes…. $XRTX is my next one I’m telling you 🚨🚨🚨 I want $1+ at minimum 🎯✅

1 · Reply

DaBullRunner Oct. 23 at 2:38 PM

As I said I don’t just talk and post I ACTUALLY BUY 👇 🚢💰💰💰💰💰💰💰 XRTX is going to $1+ imo 🎯✅ $AIRE $DVLT $BYND $SCNX $XRTX what a day

0 · Reply

honestrick Oct. 23 at 2:37 PM

$XRTX Game ON

0 · Reply

DaBullRunner Oct. 23 at 2:30 PM

$DVLT I don’t just talk and post I actually BUY👇in the .40’s!!!!!!! $XRTX is my next one 🚨🚨🚨 I want $1+ 🎯✅

1 · Reply

DaBullRunner Oct. 23 at 2:27 PM

$AIRE told you about this one too Did you listen??!!!! $SCNX told you about this one too Did you listen!!????? $DVLT told you about this one too Did you listen???!!!! $XRTX I’m telling you about this one now 🚨🚨🚨 Will you listen!!!!???!? $NMRA what a day

0 · Reply

DaBullRunner Oct. 23 at 2:24 PM

$SCNX told you I don’t just talk and post I ACTUALLY BUY 🚢🏆📦📦📦📦📦📦 Now I’m buying $XRTX 🚨🚨🚨🚨🚨🚨

1 · Reply

DaBullRunner Oct. 23 at 2:23 PM

You ignored me at $SCNX WILL YOU IGNORE ME AT $XRTX now??????

0 · Reply

DaBullRunner Oct. 23 at 2:21 PM

$XRTX anyone here have at least 100,000 shares? LIKE $SCNX 👇💰💰💰💰💰

1 · Reply

MarketMasterMind Oct. 23 at 2:19 PM

$XRTX loaded, back over $1.40 soon 🤑Ⓜ️

0 · Reply

DaBullRunner Oct. 23 at 2:18 PM

$XRTX if this doesn’t hit at least $1 TAKE MY CROWN 👑 LIKE $SCNX 👇

1 · Reply

Market Cap	3.74M
Revenue (ttm)	0.00
Net Income (ttm)	-3.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	441,300
Avg Vol	2,424,576
Day's Range	N/A - N/A
Shares Out	5.21M
Stochastic %K	4%
Beta	0.52
Analysts	Strong Buy
Price Target	$14.00